Theriva Biologics, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Theriva Biologics, Inc. (TOVX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$15.02 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-12
- Theriva Biologics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$15.02M.
- Theriva Biologics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$7.64M.
- Theriva Biologics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$8.57M.
- Theriva Biologics, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$15.32M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$15.02M 10-K · filed 2026-03-12 |
| 2024-12-31 | -$7.64M 10-K · filed 2026-03-12 |
| 2023-12-31 | -$8.57M 10-K · filed 2025-03-06 |
| 2022-12-31 | -$15.32M 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |